Published in J Exp Med on March 01, 1996
An inducible caspase 9 safety switch for T-cell therapy. Blood (2005) 2.93
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood (2007) 2.50
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. Blood (2007) 2.11
T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med (1996) 1.80
Mice with human immune system components as in vivo models for infections with human pathogens. Immunol Cell Biol (2011) 1.75
CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol (2001) 1.35
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest (2012) 1.12
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica (2010) 0.98
Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J Virol (2001) 0.98
Is human cell therapy research caught in a mousetrap? Mol Ther (2011) 0.85
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol (1998) 0.85
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. Blood (2014) 0.85
CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth. J Virol (2013) 0.79
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Exp Mol Med (2015) 0.78
Humanized mouse models of epstein-barr virus infection and associated diseases. Pathogens (2013) 0.78
Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells. BMC Cancer (2006) 0.78
Impact of γ-chain cytokines on EBV-specific T cell cultures. J Transl Med (2010) 0.76
Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders. PLoS Pathog (2014) 0.76
Translating Treg Therapy in Humanized Mice. Front Immunol (2015) 0.76
The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75
Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Cell Immunol (2015) 0.75
A severe combined immunodeficiency mutation in the mouse. Nature (1983) 13.99
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05
Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science (1992) 7.04
Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (1988) 6.38
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med (1992) 4.11
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med (1992) 3.75
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol (1985) 3.69
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med (1991) 2.20
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell (1989) 2.20
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med (1991) 2.14
Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis (1989) 1.99
NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med (1993) 1.92
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood (1988) 1.72
In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol (1990) 1.55
Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood (1994) 1.43
Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol (1991) 1.41
Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood (1988) 1.39
Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer (1991) 1.36
The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36
High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32
Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) (1991) 1.25
Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in scid mice. Immunol Rev (1991) 1.14
Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. Transplantation (1990) 1.04
Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J Immunol (1993) 0.97
Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res (1992) 0.97
Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med (1991) 0.95
Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1994) 0.94
Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res (1993) 0.90
Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice. Transplantation (1994) 0.84
Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest (1992) 0.83
Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma. Surgery (1993) 0.83
Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapy. J Immunother Emphasis Tumor Immunol (1993) 0.82
Adoptively transferred tumor-infiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes. J Immunother (1991) (1991) 0.82
Therapy of disseminated tumors by adoptive transfer of specifically immune T cells. Prog Exp Tumor Res (1988) 0.81
Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells. Cancer Res (1992) 0.79
EBV human B-cell lymphomas in Scid mice: description of the model and study of the role of anti-CD40 and anti-CD23 monoclonal antibodies in their development. Transplant Proc (1993) 0.79
Gamma-globulin modulates growth of EBV-derived B-cell tumors in SCID mice reconstituted with human lymphocytes. Int J Cancer (1993) 0.77
Reversible unfolding of individual titin immunoglobulin domains by AFM. Science (1997) 19.62
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 16.65
Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids Res (1988) 16.27
Mechanical and chemical unfolding of a single protein: a comparison. Proc Natl Acad Sci U S A (1999) 7.74
The molecular elasticity of the extracellular matrix protein tenascin. Nature (1998) 6.98
Mechanical unfolding intermediates in titin modules. Nature (1999) 6.12
Capacitance measurements reveal stepwise fusion events in degranulating mast cells. Nature (1985) 5.41
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene (2009) 4.10
BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18
Membrane patches and whole-cell membranes: a comparison of electrical properties in rat clonal pituitary (GH3) cells. J Physiol (1984) 3.17
Stepwise unfolding of titin under force-clamp atomic force microscopy. Proc Natl Acad Sci U S A (2001) 3.13
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (1998) 3.10
Atomic force microscopy reveals the mechanical design of a modular protein. Proc Natl Acad Sci U S A (2000) 3.04
Mechanical design of proteins studied by single-molecule force spectroscopy and protein engineering. Prog Biophys Mol Biol (2000) 3.00
Phase tracking: an improved phase detection technique for cell membrane capacitance measurements. Biophys J (1989) 2.86
Capacitance measurements. An analysis of the phase detector technique used to study exocytosis and endocytosis. Biophys J (1988) 2.85
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med (1994) 2.50
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res (2001) 2.48
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Polysaccharide elasticity governed by chair-boat transitions of the glucopyranose ring. Nature (1998) 2.47
The study of protein mechanics with the atomic force microscope. Trends Biochem Sci (1999) 2.34
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol (1998) 2.34
Atomic force microscopy captures length phenotypes in single proteins. Proc Natl Acad Sci U S A (1999) 2.28
Multiple conformations of PEVK proteins detected by single-molecule techniques. Proc Natl Acad Sci U S A (2001) 2.22
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22
Stretching single molecules into novel conformations using the atomic force microscope. Nat Struct Biol (2000) 2.21
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17
Point mutations alter the mechanical stability of immunoglobulin modules. Nat Struct Biol (2000) 2.12
The exocytotic fusion pore. J Cell Biol (1992) 2.10
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol (2000) 2.05
Localization of the site of Ca2+ release at the level of a single sarcomere in skeletal muscle fibres. Nature (1994) 2.05
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
The secretory granule matrix: a fast-acting smart polymer. Science (1993) 2.04
The exocytotic fusion pore and neurotransmitter release. Neuron (1994) 2.01
The exocytotic fusion pore modeled as a lipidic pore. Biophys J (1992) 1.99
Tension in secretory granule membranes causes extensive membrane transfer through the exocytotic fusion pore. Proc Natl Acad Sci U S A (1990) 1.95
Axonal stimulation for end-plate jitter studies. J Neurol Neurosurg Psychiatry (1986) 1.94
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol (2000) 1.91
Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res (1990) 1.90
IgE-mediated degranulation of mast cells does not require opening of ion channels. Nature (1986) 1.87
An indirect fluorescent-antibody technique for study of uncomplicated gonorrhea. I. Methodology. J Infect Dis (1973) 1.75
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. Eur Respir J (2011) 1.74
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol (2001) 1.72
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Single protein misfolding events captured by atomic force microscopy. Nat Struct Biol (1999) 1.67
Unfolding of titin domains explains the viscoelastic behavior of skeletal myofibrils. Biophys J (2001) 1.67
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A (1995) 1.66
Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.65
Secretory IgA antibodies in the urethral exudate of men with uncomplicated urethritis due to Neisseria gonorrhoeae. J Infect Dis (1973) 1.65
Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol (2000) 1.64
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci U S A (1992) 1.63
Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol (1994) 1.60
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood (1986) 1.60
Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood (1998) 1.60
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58
Non-Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Radiology (1994) 1.58
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol (1999) 1.58
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood (1993) 1.58
Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer (1998) 1.56
Segregation o co-transduced streptomycin and tetracycline resistance in Staphylococcus aureus. Genet Res (1972) 1.52
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood (1989) 1.52
Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. J Immunol (1977) 1.51
Pre- and postfusion regulation of transmitter release. Neuron (1997) 1.49
Colocalization of calcium entry and exocytotic release sites in adrenal chromaffin cells. Proc Natl Acad Sci U S A (1995) 1.49
Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis (1976) 1.46
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res (2000) 1.46
A patch-clamp study of histamine-secreting cells. J Gen Physiol (1986) 1.44
A low-cost method for rapid transfer function measurements with direct application to biological impedance analysis. Pflugers Arch (1981) 1.43
Fingerprinting polysaccharides with single-molecule atomic force microscopy. Nat Biotechnol (2001) 1.43
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol (2007) 1.43
An indirect fluorescent-antibody technique for study of uncomplicated gonorrhea. II. Selection and characterization of the strain of Neisseria gonorrhoeae used as antigen. J Infect Dis (1973) 1.41
Exocytotic fusion is activated by Rab3a peptides. Nature (1992) 1.41
The fusion pore and mechanisms of biological membrane fusion. Curr Opin Cell Biol (1996) 1.41
Compound versus multigranular exocytosis in peritoneal mast cells. J Gen Physiol (1990) 1.41
p53 mutations are associated with histologic transformation of follicular lymphoma. Blood (1993) 1.40
Is swelling of the secretory granule matrix the force that dilates the exocytotic fusion pore? Biophys J (1991) 1.40
Pulsed laser imaging of rapid Ca2+ gradients in excitable cells. Biophys J (1994) 1.40
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. Transplantation (1996) 1.40
Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med (1990) 1.38
Allogenic bone marrow transplantation: current status and future directions. Blood (1983) 1.36
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood (1996) 1.35
Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer (1999) 1.35
Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol (1998) 1.34
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood (2000) 1.33
ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). Am J Pathol (2000) 1.31
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation (1987) 1.31
Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med (1982) 1.30
Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood (1992) 1.29